How does topical quassia amara affect Demodex mites?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Quassia Amara and Demodex: No Evidence of Efficacy

There is no evidence that Quassia amara has any effect on Demodex mites, and it should not be used for this indication. The available evidence demonstrates that Quassia amara has been studied for seborrheic dermatitis and rosacea, but none of these studies evaluated or demonstrated anti-Demodex activity.

Evidence Review

What Quassia Amara Actually Does

Quassia amara has been studied in two small trials for facial dermatological conditions:

  • Seborrheic dermatitis: A 4% topical gel showed efficacy comparable to ketoconazole 2% and ciclopirox 1% in a 60-patient randomized trial 1
  • Rosacea: A 4% topical gel demonstrated improvement in flushing, erythema, telangiectasia, papules, and pustules in 30 patients, with results comparable to metronidazole and azelaic acid 2

The proposed mechanisms are antifungal and anti-inflammatory properties, not antiparasitic or acaricidal activity against mites 1, 2.

What Actually Works for Demodex

According to the 2024 American Academy of Ophthalmology Blepharitis Guidelines, the evidence-based treatments for Demodex include 3:

FDA-Approved First-Line:

  • Lotilaner ophthalmic solution 0.25% (FDA-approved): Twice daily for 6 weeks significantly reduces collarettes, eradicates mites, and reduces eyelid erythema 3

Alternative Evidence-Based Options:

  • Tea tree oil (containing 4-terpineol as active component): 50% solution weekly eyelid scrubs plus daily tea tree oil shampoo scrubs for minimum 6 weeks 3

    • Critical caveat: Risk of corneal epithelial defects if concentration exceeds recommendations 3
    • A Cochrane review showed uncertainty in benefits 3
  • Ivermectin: Both topical (weekly cream) and oral formulations reduce or eliminate D. folliculorum 3, 4

    • Topical ivermectin 1% shows 70.01 mites/cm² reduction and 80% decrease in Demodex-positive rates with 16-week treatment 4
  • Hypochlorous acid 0.01%: Minimal effect on Demodex 3

Clinical Bottom Line

Quassia amara has no demonstrated acaricidal activity against Demodex mites. While it may help with inflammatory skin conditions like rosacea (which can be associated with Demodex), this is through anti-inflammatory mechanisms, not mite eradication 2.

For Demodex treatment, use:

  1. Lotilaner 0.25% ophthalmic solution (first-line, FDA-approved)
  2. Topical ivermectin 1% for 16 weeks
  3. Tea tree oil preparations (with caution regarding corneal toxicity)

The confusion may arise because rosacea is associated with increased Demodex load 3, but treating rosacea inflammation is different from directly killing mites.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.